IPSC compared with SRZN: revenue, margins and what each company keeps, and the suppliers and customers both name

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

SRZNSurrozen, Inc.

Mkt capRevenueRevenue

Compare

IPSCCentury Therapeutics, Inc.

SRZNSurrozen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IPSCCentury Therapeutics, Inc.

1.54▼−8.06%

Mkt cap$275.2MRevenue$109MQ1 FY25Revenue$7MFY24

SRZNSurrozen, Inc.

29.88▼−5.60%

Regular sessionNov 5 '26

Mkt cap$732.6MRevenue$5MQ2 FY26Revenue$3MFY25

Compare

Regular sessionNov 5 '26

IPSCCentury Therapeutics, Inc.

SRZNSurrozen, Inc.

1.54▼−8.06%

Price

29.88▼−5.60%

$275.2M

Mkt cap

$732.6M

Q1 FY25$109M

Revenue

$5MQ2 FY26

FY24$7M

Revenue

$3MFY25

IPSC1.54▼−8.06%vsSRZN29.88▼−5.60%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IPSC: latest quarter not drawable. SRZN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

—Fcdiunlistedsupplier

3 more · IPSC chain ›

Shared 0

No shared counterparties.

Only SRZN 6

—Boehringer Ingelheimunlistedsupplier

—Continental Stock Transfer & Trustunlistedsupplier

—Stanford Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—TD Securities (USA)unlistedsupplier

2 more · SRZN chain ›

Price

rebased to 0%

IPSC, solidSRZN, dashed